miércoles, 21 de enero de 2026

ASCO GI Brings HER2, CLDN18.2, and KRAS Into Focus Mark A. Lewis, MD DISCLOSURES January 20, 2026

https://www.medscape.com/viewarticle/asco-gi-brings-her2-cldn18-2-and-kras-focus-2026a10001d0

No hay comentarios:

Publicar un comentario